Welcome to our dedicated page for Definitive Healthcare SEC filings (Ticker: DH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Definitive Healthcare Corp. filings document the regulatory disclosures of a public healthcare data and analytics software company. Recent Form 8-K reports furnish quarterly and annual financial-result releases covering revenue, net loss, adjusted profitability measures, cash flow, guidance, and impairment-related disclosures tied to the company’s subscription-based commercial intelligence platform.
The filing record also includes definitive proxy materials for annual stockholder matters, board elections, executive compensation, equity awards, and governance practices. Other material-event filings document board and committee composition changes, executive-role and compensation arrangements, and the termination of a nominating agreement affecting director-designation rights.
Definitive Healthcare Corp. (DH) insider Jason R. Krantz reported a transaction on 09/14/2025. The filing shows a disposition of 4,093 shares of Class A common stock at $4.15 per share, recorded as a sale to satisfy tax withholding related to vested restricted stock units. After the transaction, Mr. Krantz directly beneficially owns 1,079,380 shares and indirectly owns 450,000 shares held in trust by DH Holdings (formerly the Jason R. Krantz 2009 Trust). The filing was signed by an attorney-in-fact on 09/16/2025.
On 08/01/2025, Definitive Healthcare Corp. (DH) Chief Financial Officer Casey Heller filed a Form 4 reporting a routine tax-withholding transaction. The company withheld 1,244 Class A common shares (transaction code F) at an implied price of $3.74 per share to cover federal taxes triggered by the vesting of previously granted restricted stock units. Following the withholding, Heller still directly owns 1,089,721 shares, preserving the vast majority of his stake. No open-market purchase or discretionary sale occurred, and there were no derivative security movements disclosed. The filing is administrative in nature and does not indicate a change in role, outlook, or insider sentiment.
Form 4 filed 08/05/2025 discloses that Definitive Healthcare (DH) Chief Operating Officer Kate Marie Shamsuddin satisfied tax-withholding obligations from previously granted restricted stock units. On 08/01/2025 she surrendered 4,741 Class A common shares to the issuer at an imputed price of $3.74; no cash was received. The transaction is coded “F,” indicating share withholding rather than an open-market sale.
After the withholding, Shamsuddin directly owns 694,149 DH shares. No derivative securities were acquired or disposed of, and no additional insider transactions were reported. The surrendered shares equal roughly 0.7 % of her post-transaction holdings, suggesting minimal impact on insider ownership concentration or public float.
Definitive Healthcare Corp. (DH) – Form 3 filing
The filing records the initial beneficial ownership position of newly listed insider Jonathan Paris, who became Chief Legal Officer on 16 June 2025. According to the disclosure, Paris currently reports no direct or indirect ownership of DH securities. An Exhibit 24 Power of Attorney is included, authorising future Section 16 filings on his behalf. No derivatives, options, or other equity instruments are listed. The submission is made on an individual basis and bears a manual signature dated 18 June 2025.
Because no securities are owned and no transactions are reported, the document is largely administrative and carries minimal immediate financial impact for investors.